Product Images Gabapentin

Gabapentin is a medication available in tablets form. Each bottle has a quantity of 120. The manufacturer of the 800mg tablets is ScieGen Pharmaceuticals, Inc. located in Hauppauge, NY. Customers should store the tablets between 20-26°C (63-77°F); excursions to 15-30°C (59-86°F) are permitted [See USP]. The Repackaging of this medication was carried out by Remedy Repack Inc located in Indiana, PA. See package insert for directions on usage. This medication is available via prescription only.*

Gabapentin is a medication that comes in the form of a tablet with a strength of 800 mg. The National Drug Code (NDC) for this medication is 70518-2776-00, and it is manufactured by ScieGen Pharmaceuticals, Inc. located in Hauppauge, NY. The lot number and expiration date are not mentioned in the text. The packaging of this medication should be stored at a temperature between 20-26°C (63-77°F) with permitted excursions to 15-30°C (59-86°F). The medication should be kept out of reach of children. The package insert should be consulted for directions on how to use this medication, and it is available through Repack RX ONLY by RemedyRepack Inc. in Indiana, PA.*

This appears to be a table with information related to mean pain scores and the dosage of a medication (Parkod) being titrated over the course of several weeks. There is also a comparison between a placebo and Gabapentin at a daily dosage of 3600 mg. The first row of the table lists the mean pain score as 0. The next two rows are likely related to different methods of administration for Parkod. The fourth and fifth rows are labeled "Placebo" and "Gabapentin, 3600 mg/day" respectively. The final row is labeled "Baseline" with "Weeks" listed in the second column, suggesting that the table is describing the change in pain score over time.*

This is a graph showing the results of a study on the effects of different doses of gabapentin on pain levels over a 4 week period. The x-axis represents the weeks of the study and the y-axis represents the mean pain score. The study had a 3-week dose titration period followed by a 4-week fixed dose period. The three groups being studied were a placebo group, a group taking 1800mg/day of gabapentin, and a group taking 2400mg/day of gabapentin. The mean pain scores of each group are graphed over the 7 weeks of the study.*